NEO

#2405
NeoGenomics, Inc.
8.35 USD
+4.37%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
8.35
8.35
Rango anual
4.72
13.74
Cambio diario
+4.37%
Variación mensual
+3.99%
Variación en los últimos 6 meses
-12.11%
Cambio anual
-13.20%
Cierres anteriores
8.00
Abrir
8.35
Bid
Ask
Mínimo
8.35
High
8.35
Volumen
75
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.08 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-14
Relación precio/flujo de caja
2.07

NeoGenomics Inc

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

Noticias